News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
804,601 Results
Type
Article (74747)
Company Profile (434)
Press Release (729419)
Multimedia
Podcasts (123)
Webinars (18)
Section
Business (222891)
Career Advice (3028)
Deals (38423)
Drug Delivery (124)
Drug Development (88757)
Employer Resources (186)
FDA (17826)
Job Trends (16434)
News (379929)
Policy (37678)
Tag
Academia (2975)
Academic (1)
Accelerated approval (12)
Adcomms (32)
Allergies (106)
Alliances (55258)
ALS (119)
Alzheimer's disease (1571)
Antibody-drug conjugate (ADC) (182)
Approvals (17777)
Artificial intelligence (360)
Autoimmune disease (36)
Automation (19)
Bankruptcy (394)
Best Places to Work (12367)
BIOSECURE Act (22)
Biosimilars (135)
Biotechnology (295)
Bladder cancer (100)
Brain cancer (40)
Breast cancer (388)
Cancer (3074)
Cardiovascular disease (249)
Career advice (2549)
Career pathing (33)
CAR-T (207)
CDC (41)
Cell therapy (564)
Cervical cancer (24)
Clinical research (72398)
Collaboration (1107)
Company closure (3)
Compensation (711)
Complete response letters (34)
COVID-19 (2899)
CRISPR (67)
C-suite (355)
Cystic fibrosis (121)
Data (3083)
Decentralized trials (2)
Denatured (36)
Depression (76)
Diabetes (378)
Diagnostics (6884)
Digital health (25)
Diversity (9)
Diversity, equity & inclusion (47)
Drug discovery (158)
Drug pricing (149)
Drug shortages (34)
Duchenne muscular dystrophy (135)
Earnings (92479)
Editorial (48)
Employer branding (23)
Employer resources (162)
Events (125305)
Executive appointments (906)
FDA (19556)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (1002)
Gene editing (147)
Generative AI (28)
Gene therapy (434)
GLP-1 (932)
Government (5068)
Grass and pollen (6)
Guidances (181)
Healthcare (20451)
HIV (44)
Huntington's disease (32)
IgA nephropathy (44)
Immunology and inflammation (184)
Immuno-oncology (11)
Indications (40)
Infectious disease (3095)
Inflammatory bowel disease (165)
Inflation Reduction Act (11)
Influenza (69)
Intellectual property (125)
Interviews (557)
IPO (17528)
IRA (52)
Job creations (4503)
Job search strategy (2126)
Kidney cancer (14)
Labor market (52)
Layoffs (581)
Leadership (25)
Legal (9422)
Liver cancer (85)
Longevity (12)
Lung cancer (431)
Lymphoma (215)
Machine learning (11)
Management (63)
Manufacturing (431)
MASH (99)
Medical device (14429)
Medtech (14434)
Mergers & acquisitions (21631)
Metabolic disorders (964)
Multiple sclerosis (104)
NASH (23)
Neurodegenerative disease (140)
Neuropsychiatric disorders (41)
Neuroscience (2322)
NextGen: Class of 2025 (7299)
Non-profit (5023)
Now hiring (48)
Obesity (496)
Opinion (277)
Ovarian cancer (104)
Pain (121)
Pancreatic cancer (125)
Parkinson's disease (200)
Partnered (23)
Patents (319)
Patient recruitment (172)
Peanut (55)
People (63515)
Pharmaceutical (93)
Pharmacy benefit managers (25)
Phase I (22423)
Phase II (31573)
Phase III (23735)
Pipeline (1700)
Policy (239)
Postmarket research (3257)
Preclinical (10045)
Press Release (72)
Prostate cancer (150)
Psychedelics (46)
Radiopharmaceuticals (278)
Rare diseases (527)
Real estate (6916)
Recruiting (73)
Regulatory (25926)
Reports (52)
Research institute (2649)
Resumes & cover letters (483)
Rett syndrome (10)
RNA editing (10)
RSV (58)
Schizophrenia (98)
Series A (171)
Series B (116)
Service/supplier (21)
Sickle cell disease (67)
Special edition (22)
Spinal muscular atrophy (167)
Sponsored (37)
Startups (4082)
State (2)
Stomach cancer (17)
Supply chain (83)
Tariffs (65)
The Weekly (85)
Vaccines (910)
Venture capital (58)
Weight loss (330)
Women's health (50)
Worklife (20)
Date
Today (98)
Last 7 days (386)
Last 30 days (1955)
Last 365 days (33147)
2025 (17999)
2024 (37431)
2023 (42274)
2022 (53659)
2021 (58387)
2020 (57172)
2019 (50406)
2018 (38238)
2017 (35982)
2016 (36635)
2015 (42744)
2014 (37292)
2013 (33438)
2012 (35214)
2011 (35440)
2010 (34486)
Location
Africa (1058)
Alabama (68)
Alaska (7)
Arizona (269)
Arkansas (13)
Asia (46461)
Australia (7982)
California (7740)
Canada (2411)
China (722)
Colorado (335)
Connecticut (345)
Delaware (201)
Europe (106409)
Florida (1156)
Georgia (264)
Hawaii (2)
Idaho (64)
Illinois (704)
India (30)
Indiana (381)
Iowa (17)
Japan (238)
Kansas (114)
Kentucky (32)
Louisiana (16)
Maine (73)
Maryland (1089)
Massachusetts (5852)
Michigan (258)
Minnesota (478)
Mississippi (3)
Missouri (99)
Montana (32)
Nebraska (26)
Nevada (82)
New Hampshire (71)
New Jersey (2178)
New Mexico (31)
New York (2177)
North Carolina (1219)
North Dakota (10)
Northern California (3358)
Ohio (248)
Oklahoma (16)
Oregon (40)
Pennsylvania (1653)
Puerto Rico (18)
Rhode Island (36)
South America (1452)
South Carolina (36)
South Dakota (1)
Southern California (2883)
Tennessee (129)
Texas (1171)
United States (29033)
Utah (229)
Virginia (202)
Washington D.C. (80)
Washington State (666)
West Virginia (4)
Wisconsin (83)
804,601 Results for "huntingdon s disease research group chdi foundation inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
May 28, 2025
·
4 min read
Business
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
Evotec SE has announced the extension of its 20-year collaboration with CHDI Foundation, Inc. CHDI is a privately funded nonprofit biomedical research organisation exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease.
May 28, 2024
·
5 min read
Press Releases
Evestia Clinical to merge with Atlantic Research Group
July 16, 2025
·
5 min read
Legal
Medical Groups Sue RFK Jr. Over ‘Baseless and Uninformed’ Changes to COVID-19 Vaccine Policy
Societies, including the American Academy of Pediatrics, allege that Kennedy’s directive to remove COVID-19 from vaccination guidelines for healthy pregnant women and healthy children puts these vulnerable groups at risk of serious illness.
July 8, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Lung Cancer Research Foundation Adds $3.75 Million in Research Funding Opportunities
July 16, 2025
·
4 min read
Press Releases
C2N Diagnostics Expands Portfolio of Blood Tests for Clinical Researchers Studying Alzheimer’s Disease and Related Dementias
July 15, 2025
·
4 min read
Press Releases
Prima Mente Launches Pleiades, a Large-Scale Human Whole-Epigenome Foundation Model with Clinical Applications for Alzheimer’s Disease
July 16, 2025
·
4 min read
BioMidwest
Geneoscopy to Present Research on Inflammatory Bowel Disease at Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference
Geneoscopy, Inc. will present research at the Crohn’s & Colitis Foundation’s IBD Innovate 2024 Conference in Cambridge, Mass., April 9-10.
April 3, 2024
·
2 min read
Press Releases
UCB presents latest thymidine kinase 2 deficiency (TK2d) research at the United Mitochondrial Disease Foundation (UMDF) 2025 Conference
June 20, 2025
·
7 min read
Press Releases
Lung Cancer Research Foundation Announces New Research Collaboration with Boehringer Ingelheim
June 17, 2025
·
6 min read
1 of 80,461
Next
